Browse Arkansas Code titles and sections
10 U.S.C. § 1074h — Medical and dental care: medal of honor
Federal law — U.S. Code and appendices · legal_authorities
Page 1066
TITLE 10—ARMED FORCES
§ 1074h
tion project throughout the entire pharmacy benefits
program or at a limited number of sites. If the
project is conducted at a limited number of sites, the
number of sites shall be not less than five in each
TRICARE region for each of the two means described
in such subparagraph.
‘‘(3) PERIOD
OF
DEMONSTRATION.—The Secretary
shall provide for conducting the demonstration
project for a period of time necessary to evaluate the
feasibility and cost effectiveness of the demonstra-
tion. Such period shall be at least as long as the pe-
riod covered by pharmacy contracts in existence on
the date of the enactment of this Act [Oct. 17, 2006]
(including any extensions of the contracts), or five
years, whichever is shorter.
‘‘(4) IMPLEMENTATION DEADLINE.—Implementation of
the demonstration project shall begin not later than
May 1, 2007.
‘‘(c) EVALUATION
OF DEMONSTRATION PROJECT.—The
Secretary shall evaluate the demonstration project for
the following:
‘‘(1) The costs and benefits of providing OTC drugs
under the pharmacy benefits program in each of the
means chosen by the Secretary to conduct the dem-
onstration project.
‘‘(2) The clinical effectiveness of providing OTC
drugs under the pharmacy benefits program.
‘‘(3) Customer satisfaction with the demonstration
project.
‘‘(d) REPORT.—Not later than two years after imple-
mentation of the demonstration project begins, the
Secretary shall submit to the Committees on Armed
Services of the Senate and House of Representatives a
report on the demonstration project. The report shall
contain—
‘‘(1) the evaluation required by subsection (c);
‘‘(2) recommendations for improving the provision
of OTC drugs under the pharmacy benefits program;
and
‘‘(3) recommendations
Source: Supplied 2024 U.S. Code historical extraction · 10 U.S.C. § 1074h
Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: ff972e50c491e12dec41add2e71909acd05ca34ef8817275d1157981f7d2bc6f. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:usc2024-3b8941eb254e66117741f6b5
Source file: Laws/federal/codes/united-states-code-2024/title-10/section-1074h-medical-and-dental-care-medal-of-honor--5e693ec792.md
Pages: Not recorded – Not recorded
Passage SHA-256: d8f00dfc4b21ad6cc3147965da99eca6d36da12f88de181c9e0600c9b4fc9110
Source location: USCODE-2024-title10-subtitleA-partII-chap55-sec1074h.pdf
Stored source content
Page 1066
TITLE 10—ARMED FORCES
§ 1074h
tion project throughout the entire pharmacy benefits
program or at a limited number of sites. If the
project is conducted at a limited number of sites, the
number of sites shall be not less than five in each
TRICARE region for each of the two means described
in such subparagraph.
‘‘(3) PERIOD
OF
DEMONSTRATION.—The Secretary
shall provide for conducting the demonstration
project for a period of time necessary to evaluate the
feasibility and cost effectiveness of the demonstra-
tion. Such period shall be at least as long as the pe-
riod covered by pharmacy contracts in existence on
the date of the enactment of this Act [Oct. 17, 2006]
(including any extensions of the contracts), or five
years, whichever is shorter.
‘‘(4) IMPLEMENTATION DEADLINE.—Implementation of
the demonstration project shall begin not later than
May 1, 2007.
‘‘(c) EVALUATION
OF DEMONSTRATION PROJECT.—The
Secretary shall evaluate the demonstration project for
the following:
‘‘(1) The costs and benefits of providing OTC drugs
under the pharmacy benefits program in each of the
means chosen by the Secretary to conduct the dem-
onstration project.
‘‘(2) The clinical effectiveness of providing OTC
drugs under the pharmacy benefits program.
‘‘(3) Customer satisfaction with the demonstration
project.
‘‘(d) REPORT.—Not later than two years after imple-
mentation of the demonstration project begins, the
Secretary shall submit to the Committees on Armed
Services of the Senate and House of Representatives a
report on the demonstration project. The report shall
contain—
‘‘(1) the evaluation required by subsection (c);
‘‘(2) recommendations for improving the provision
of OTC drugs under the pharmacy benefits program;
and
‘‘(3) recommendations on whether permanent au-
thority should be provided to cover OTC drugs under
the pharmacy benefits program.
‘‘(e) CONTINUATION
OF DEMONSTRATION PROJECT.—If
the Secretary recommends in the report under sub-
section (d) that permanent authority should be pro-
vided, the Secretary may continue the demonstration
project for up to one year after submitting the report.
‘‘(f) DEFINITIONS.—In this section:
‘‘(1) The term ‘drug’ means a drug, including a bio-
logical product, within the meaning of section
1074g(f)(2) [now 1074g(i)(2)] of title 10, United States
Code.
‘‘(2) The term ‘OTC drug’ has the meaning indicated
for such term in subsection (b)(1)(A).
‘‘(3) The term ‘over-the-counter drug’ means a drug
that is not subject to section 503(b) of the Federal
Food, Drug, and Cosmetic Act [21 U.S.C. 353(b)].
‘‘(4) The term ‘prescription drug’ means a drug that
is subject to section 503(b) of the Federal Food, Drug,
and Cosmetic Act.’’
INTEROPERABILITY
OF DEPARTMENT
OF VETERANS AF-
FAIRS
AND
DEPARTMENT
OF
DEFENSE
PHARMACY
DATA SYSTEMS
Pub. L. 107–314, div. A, title VII, § 724, Dec. 2, 2002, 116
Stat. 2598, provided that:
‘‘(a) INTEROPERABILITY.—The Secretary of Veterans
Affairs and the Secretary of Defense shall seek to en-
sure that on or before October 1, 2004, the Department
of Veterans Affairs pharmacy data system and the De-
partment of Defense pharmacy data system (known as
the ‘Pharmacy Data Transaction System’) are inter-
operable for both Department of Defense beneficiaries
and Department of Veterans Affairs beneficiaries by
achieving real-time interface, data exchange, and
checking of prescription drug data of outpatients, and
using national standards for the exchange of outpatient
medication information.
‘‘(b) ALTERNATIVE REQUIREMENT.—If the interoper-
ability specified in subsection (a) is not achieved by Oc-
tober 1, 2004, as determined jointly by the Secretary of
Defense and the Secretary of Veterans Affairs, the Sec-
retary of Veterans Affairs shall adopt the Department
of Defense Pharmacy Data Transaction System for use
by the Department of Veterans Affairs health care sys-
tem. Such system shall be fully operational not later
than October 1, 2005.
‘‘(c) IMPLEMENTATION FUNDING FOR ALTERNATIVE RE-
QUIREMENT.—The Secretary of Defense shall transfer to
the Secretary of Veterans Affairs, or shall otherwise
bear the cost of, an amount sufficient to cover three-
fourths of the cost to the Department of Veterans Af-
fairs for computer programming activities and relevant
staff training expenses related to implementation of
subsection (b). Such amount shall be determined in
such manner as agreed to by the two Secretaries.’’
DEADLINE FOR ESTABLISHMENT OF COMMITTEE
Pub. L. 106–65, div. A, title VII, § 701(b), Oct. 5, 1999,
113 Stat. 680, directed the Secretary of Defense to es-
tablish the Pharmacy and Therapeutics Committee re-
quired by subsec. (b) of this section not later than 30
days after Oct. 5, 1999.
REPORTS REQUIRED
Pub. L. 106–65, div. A, title VII, § 701(c), Oct. 5, 1999,
113 Stat. 680, directed the Secretary of Defense to sub-
mit reports to Congress, not later than Apr. 1 and Oct.
1 of fiscal years 2000 and 2001, on the implementation of
the uniform formulary required under subsec. (a) of
this section, the results of a survey conducted by the
Secretary of prescribers for military medical treatment
facilities and TRICARE contractors, the operation of
the Pharmacy Data Transaction Service required by
subsec. (e) of this section, and any other actions taken
by the Secretary to improve management of the phar-
macy benefits program under this section.
STUDY FOR DESIGN OF PHARMACY BENEFIT FOR
CERTAIN COVERED BENEFICIARIES
Pub. L. 106–65, div. A, title VII, § 701(d), Oct. 5, 1999,
113 Stat. 680, required the Secretary of Defense to pre-
pare and submit to Congress, by Apr. 15, 2001, a study
on a design for a comprehensive pharmacy benefit for
covered beneficiaries under chapter 55 of title 10, who
are entitled to benefits under part A, and enrolled
under part B, of title XVIII of the Social Security Act,
and to provide an estimate of the costs of imple-
menting and operating such design, prior to repeal by
Pub. L. 107–107, div. A, title VII, § 723, Dec. 28, 2001, 115
Stat. 1168.
§ 1074h. Medical and dental care: medal of honor
recipients; dependents
(a) MEDAL
OF HONOR RECIPIENTS.—A former
member of the armed forces who is a Medal of
Honor recipient and who is not otherwise enti-
tled to medical and dental benefits under this
chapter may, upon request, be given medical and
dental care provided by the administering Secre-
taries in the same manner as if entitled to re-
tired pay.
(b) IMMEDIATE DEPENDENTS.—A person who is
an immediate dependent of a Medal of Honor re-
cipient and who is not otherwise entitled to
medical and dental benefits under this chapter
may, upon request, be given medical and dental
care provided by the administering Secretaries
in the same manner as if the Medal of Honor re-
cipient were, or (if deceased) was at the time of
death, entitled to retired pay.
(c) DEFINITIONS.—In this section:
(1) The term ‘‘Medal of Honor recipient’’
means a person who has been awarded a medal
of honor under section 7271, 8291, or 9271 of this
title or section 2732 of title 14.
Page 1067
TITLE 10—ARMED FORCES
§ 1074i
(2) The term ‘‘immediate dependent’’ means
a dependent described in subparagraph (A),
(B), (C), or (D) of section 1072(2) of this title.
(Added Pub. L. 106–398, § 1 [[div. A], title VII,
§ 706(a)(1)], Oct. 30, 2000, 114 Stat. 1654, 1654A–175;
amended Pub. L. 115–232, div. A, title VIII,
§ 809(a), Aug. 13, 2018, 132 Stat. 1840; Pub. L.
118–31, div. A, title XVIII, § 1801(a)(11), Dec. 22,
2023, 137 Stat. 684.)
Editorial Notes
AMENDMENTS
2023—Subsec. (c)(1). Pub. L. 118–31, § 1801(a)(11), sub-
stituted ‘‘section 2732 of title 14’’ for ‘‘section 491 of
title 14’’.
2018—Subsec. (c)(1). Pub. L. 115–232 substituted ‘‘sec-
tion 7271, 8291, or 9271’’ for ‘‘section 3741, 6241, or 8741’’.
Statutory Notes and Related Subsidiaries
EFFECTIVE DATE OF 2018 AMENDMENT
Amendment by Pub. L. 115–232 effective Feb. 1, 2019,
with provision for the coordination of amendments and
special rule for certain redesignations, see section 800
of Pub. L. 115–232, set out as a note preceding section
3001 of this title.
EFFECTIVE DATE
Pub. L. 106–398, § 1 [[div. A], title VII, § 706(b)], Oct. 30,
2000, 114 Stat. 1654, 1654A–175, provided that: ‘‘Section
1074h of title 10, United States Code, shall apply with
respect to medical and dental care provided on or after
the date of the enactment of this Act [Oct. 30, 2000].’’
§ 1074i. Reimbursement for certain travel ex-
penses
(a) IN GENERAL.—In any case in which a cov-
ered beneficiary is referred by a primary care
physician to a specialty care provider who pro-
vides services more than 100 miles from the loca-
tion in which the primary care provider provides
services to the covered beneficiary, the Sec-
retary of Defense shall provide travel and trans-
portation allowances as specified in regulations
prescribed under section 464 of title 37 for the
covered beneficiary and, when accompaniment
by an adult is necessary, for a parent or guard-
ian of the covered beneficiary or another mem-
ber of the covered beneficiary’s family who is at
least 21 years of age.
(b) ALLOWABLE TRAVEL AND TRANSPORTATION
UNDER EXCEPTIONAL CIRCUMSTANCES.—The Sec-
retary of Defense may provide travel and trans-
portation allowances as specified in the regula-
tions referred to in subsection (a) for travel of
members of the armed forces on active duty and
their dependents, and accompaniment, to a spe-
cialty care provider not otherwise authorized by
subsection (a) under such exceptional cir-
cumstances as the Secretary considers appro-
priate for purposes of this section.
(c) OUTREACH
PROGRAM
AND
TRAVEL
REIM-
BURSEMENT FOR FOLLOW-ON SPECIALTY CARE AND
RELATED
SERVICES.—The Secretary concerned
shall ensure that an outreach program is imple-
mented for each member of the uniformed serv-
ices who incurred a combat-related disability
and is entitled to retired or retainer pay, or
equivalent pay, so that—
(1) the progress of the member is closely
monitored; and
(2) the member receives the travel reim-
bursement authorized by subsection (a) when-
ever the member requires follow-on specialty
care, services, or supplies.
(d) DEFINITIONS.—In this section:
(1) The term ‘‘specialty care provider’’ in-
cludes a dental specialist.
(2) The term ‘‘dental specialist’’ means an
oral surgeon, orthodontist, prosthodontist, pe-
riodontist, endodontist, or pediatric dentist,
and includes such other providers of dental
care and services as determined appropriate by
the Secretary of Defense.
(3) The term ‘‘combat-related disability’’ has
the meaning given that term in section 1413a
of this title.
(Added Pub. L. 106–398, § 1 [[div. A], title VII,
§ 758(a)], Oct. 30, 2000, 114 Stat. 1654, 1654A–199;
amended Pub. L. 107–107, div. A, title VII, § 706,
Dec. 28, 2001, 115 Stat. 1163; Pub. L. 108–136, div.
A, title VII, § 712, Nov. 24, 2003, 117 Stat. 1530;
Pub. L. 110–181, div. A, title XVI, § 1632(a), (b),
Jan. 28, 2008, 122 Stat. 458, 459; Pub. L. 111–84,
div. A, title VI, § 634, Oct. 28, 2009, 123 Stat. 2363;
Pub. L. 113–66, div. A, title VI, § 621(d), Dec. 26,
2013, 127 Stat. 784.)
Editorial Notes
AMENDMENTS
2013—Subsec. (a). Pub. L. 113–66, § 621(d)(1), sub-
stituted ‘‘travel and transportation allowances as spec-
ified in regulations prescribed under section 464 of title
37’’ for ‘‘reimbursement for reasonable travel ex-
penses’’.
Subsec. (b). Pub. L. 113–66, § 621(d)(2), substituted ‘‘AL-
LOWABLE TRAVEL AND TRANSPORTATION UNDER EXCEP-
TIONAL CIRCUMSTANCES.—The Secretary of Defense may
provide travel and transportation allowances as speci-
fied in the regulations referred to in subsection (a) for’’
for ‘‘REIMBURSEMENT FOR TRAVEL UNDER EXCEPTIONAL
CIRCUMSTANCES.—The Secretary of Defense may pro-
vide reimbursement for reasonable travel expenses of’’.
2009—Subsec. (a). Pub. L. 111–84, § 634(b), inserted ‘‘of
Defense’’ after ‘‘the Secretary’’.
Subsecs. (b) to (d). Pub. L. 111–84, § 634(a), added sub-
sec. (b) and redesignated former subsecs. (b) and (c) as
(c) and (d), respectively.
2008—Subsecs. (b), (c). Pub. L. 110–181, § 1632(a), added
subsec. (b) and redesignated former subsec. (b) as (c).
Subsec. (c)(3). Pub. L. 110–181, § 1632(b), added par. (3).
2003—Pub. L. 108–136 inserted ‘‘(a) IN GENERAL.—’’ be-
fore ‘‘In any case’’ and added subsec. (b).
2001—Pub. L. 107–107 inserted before period at end
‘‘and, when accompaniment by an adult is necessary,
for a parent or guardian of the covered beneficiary or
another member of the covered beneficiary’s family
who is at least 21 years of age’’.
Statutory Notes and Related Subsidiaries
EFFECTIVE DATE OF 2008 AMENDMENT
Pub. L. 110–181, div. A, title XVI, § 1632(c), Jan. 28,
2008, 122 Stat. 459, provided that: ‘‘Subsection (b) of sec-
tion 1074i of title 10, United States Code, as added by
subsection (a)(2), shall apply with respect to travel de-
scribed in subsection (a) of such section that occurs on
or after January 1, 2008, for follow-on specialty care,
services, or supplies.’’
GUIDANCE
ON
AUTHORITY
TO
PROVIDE
TRAVEL
AND
TRANSPORTATION ALLOWANCES
FOR SPECIALTY CARE
UNDER EXCEPTIONAL CIRCUMSTANCES
Pub. L. 118–159, div. A, title VII, § 706, Dec. 23, 2024, 138
Stat. 1944, provided that: ‘‘Not later than one year after
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Medal of Honor Recipients.—** A former member of the armed forces who is a Medal of Honor recipient and who is not otherwise entitled to medical and dental benefits under this chapter may, upon request, be given medical and dental care provided by the administering Secretaries in the same manner as if entitled to retired pay.
**(b) Immediate Dependents.—** A person who is an immediate dependent of a Medal of Honor recipient and who is not otherwise entitled to medical and dental benefits under this chapter may, upon request, be given medical and dental care provided by the administering Secretaries in the same manner as if the Medal of Honor recipient were, or (if deceased) was at the time of death, entitled to retired pay.
**(c) Definitions.—** In this section:
(1) The term “Medal of Honor recipient” means a person who has been awarded a medal of honor under section 7271, 8291, or 9271 of this title or [section 2732 of title 14](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title14-section2732&num=0&edition=prelim).
(2) The term “immediate dependent” means a dependent described in subparagraph (A), (B), (C), or (D) of [section 1072(2) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title10-section1072/2&num=0&edition=prelim).
Source: Supplied U.S. Code snapshot — release unconfirmed · 10 U.S.C. § 1074h
Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Regulations for goods to be processed, labeled, or repacked elsewhere** The Secretary is directed to promulgate regulations exempting from any labeling or packaging requirement of this chapter drugs and devices which are, in accordance with the practice of the trade, to be processed, labeled, or repacked in substantial quantities at establishments other than those where originally processed or packed, on condition that such drugs and devices are not adulterated or misbranded under the provisions of this chapter upon removal from such processing, labeling, or repacking establishment.
**(b) Prescription by physician; exemption from labeling and prescription requirements; misbranded drugs; compliance with narcotic and marihuana laws**
(1) A drug intended for use by man which—
(A) because of its toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use, is not safe for use except under the supervision of a practitioner licensed by law to administer such drug; or
(B) is limited by an approved application under [section 355 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section355&num=0&edition=prelim) to use under the professional supervision of a practitioner licensed by law to administer such drug;
shall be dispensed only (i) upon a written prescription of a practitioner licensed by law to administer such drug, or (ii) upon an oral prescription of such practitioner which is reduced promptly to writing and filed by the pharmacist, or (iii) by refilling any such written or oral prescription if such refilling is authorized by the prescriber either in the original prescription or by oral order which is reduced promptly to writing and filed by the pharmacist.
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 353
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 353. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 167
TITLE 21—FOOD AND DRUGS
§ 353
COUNTERFEITING OF DRUGS; CONGRESSIONAL FINDINGS
AND DECLARATION OF POLICY
Pub. L. 89–74, § 9(a), July 15, 1965, 79 Stat. 234, provided
that: ‘‘The Congress finds and declares that there is a
substantial traffic in counterfeit drugs simulating the
brand or other identifying mark or device of the manu-
facturer of the genuine article; that such traffic poses
a serious hazard to the health of innocent consumers of
such drugs because of the lack of proper qualifications,
facilities, and manufacturing controls on the part of
the counterfeiter, whose operations are clandestine;
that, while such drugs are deemed misbranded within
the meaning of section 502(i) of the Federal Food, Drug,
and Cosmetic Act [21 U.S.C. 352(i)], the controls for the
suppression of the traffic in such drugs are inadequate
because of the difficulty of determining the place of
interstate origin of such drugs and, if that place is dis-
covered, the fact that the implements for counter-
feiting are not subject to seizure, and that these factors
require enactment of additional controls with respect
to such drugs without regard to their interstate or
intrastate origins.’’
Provisions as effective Feb. 1, 1966, see section 11 of
Pub. L. 89–74, set out as an Effective Date of 1965
Amendment note under section 321 of this title.
Executive Documents
TRANSFER OF FUNCTIONS
For transfer of functions of Federal Security Admin-
istrator to Secretary of Health, Education, and Welfare
[now Health and Human Services], and of Food and
Drug Administration in the Department of Agriculture
to Federal Security Agency, see notes set out under
section 321 of this title.
§ 353. Exemptions and consideration for certain
drugs, devices, and biological products
(a)
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 353
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 353. This identifies an authority to review, not proof of applicability.